Abstract Background: Calcitonin gene-related peptide (CGRP) release from trigeminal structures is central to migraine pathophysiology. This study employed an ex…
Abstract Cannabis remains by far the most consumed illicit drug in Europe. The availability of more potent cannabis has raised…
Abstract The mesolimbic reward system originating from dopamine neurons in the ventral tegmental area (VTA) of the midbrain shows a…
Abstract Rationale: Adolescent cannabis use is linked to later-life changes in cognition, learning, and memory. Rodent experimental studies suggest Δ9-tetrahydrocannabinol…
Abstract Background: Interactions between the endocannabinoid system (ECS) and neurotransmitter systems might mediate the risk of developing a schizophrenia spectrum…
Abstract Cannabidiol (CBD) appears to possess some neuroprotective properties, but experimental data are still inconsistent. Therefore, this in vitro study…
Abstract Earlier age of cannabis usage poses higher risk of Cannabis Use Disorder and adverse consequences, such as addiction, anxiety,…
Abstract Medicinal cannabis has shown promise for the symptomatic treatment of Parkinson’s disease (PD), but patient exposure to whole plant…
Abstract Mepirapim is a synthetic cannabinoid that has recently been abused for recreational purposes. Although serious side effects have been…
Abstract Eukaryotic mRNAs possess a poly(A) tail at their 3′-end, to which poly(A)-binding protein C1 (PABPC1) binds and recruits other…